People · Operator
Named in public records as an officer, director or promoter · active 2010–2018 · Pharmaceuticals, Other Health Care, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Tivorsan Pharmaceuticals, Inc. | — | Pharmaceuticals | Series A | $13.8M | $27.9M | 2011 |
| Correx Inc | — | Other Health Care | Seed | $6.5M | $11.2M | 2011 |
| NexGen Medical Systems Inc | — | Healthtech | Seed | $3.5M | $13.4M | 2010 |
Joel Braunstein at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Joel Braunstein on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Paul Buckman | 1 | 10 |
| Rudy Mazzocchi | 1 | 6 |
| Jay Venkatesan | 1 | 5 |
| Michael Meyers | 1 | 5 |
| MARK STAUTBERG | 1 | 3 |
| James Connolly | 1 | 3 |
| Denis Harrington | 1 | 3 |
| Patrick Mullaney | 1 | 2 |
| Matt Olson | 1 | 2 |
| Patrick Howe | 1 | 2 |
| Justin Fallon | 1 | 1 |
| Michael Fredrick | 1 | 1 |
| Paul Abrams | 1 | 1 |
| Mike Frederick | 1 | 1 |
| J. Alan Crunkleton | 1 | 1 |
| Richard Latchaw | 1 | 1 |
| John Kucharczyk | 1 | 1 |
| Cary Adams | 1 | 1 |
| Matthew Solar | 1 | 1 |
| Dino De Cicco | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.